ArticleDer Internist2015
[Salt restriction in people with hypertension and patients with cardiovascular disease : meaningfulness and extent].
Article in Der Internist, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
unlabelledThe association between high salt (NaCl) intake and increased blood pressure has been demonstrated in a multitude of studies. Clear evidence for a blood pressure lowering effect of a reduction in dietary NaCl has also been reported. In contrast to the antihypertensive effect of NaCl reduction, from a clinical scientific perspective a positive effect on cardiovascular mortality has not been sufficiently demonstrated. Often the proven blood pressure lowering effect of reduced NaCl intake was extrapolated to an effect on the cardiovascular risk. This article describes the current data situation and discusses the effects of NaCl restriction in people with hypertension and patients with cardiovascular diseases in detail. IN SUMMARY: moderate restriction of NaCl to 6 g/day is recommended for patients with hypertension or cardiovascular comorbidities, intensive reduction to ≤3 g/day is not recommended and for patients with few comorbidities an NaCl intake of up to 10 g/day has no obvious disadvantages.
Indexed as
Identifiers
26066590What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.